BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 9922303)

  • 1. The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies.
    Lind T; Mégraud F; Unge P; Bayerdörffer E; O'morain C; Spiller R; Veldhuyzen Van Zanten S; Bardhan KD; Hellblom M; Wrangstadh M; Zeijlon L; Cederberg C
    Gastroenterology; 1999 Feb; 116(2):248-53. PubMed ID: 9922303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
    Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
    Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The OAC and OMC options.
    Unge P
    Eur J Gastroenterol Hepatol; 1999 Aug; 11 Suppl 2():S9-17; discussion S23-4. PubMed ID: 10503817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HOMER Study: the effect of increasing the dose of metronidazole when given with omeprazole and amoxicillin to cure Helicobacter pylori infection.
    Bardhan K; Bayerdörffer E; Veldhuyzen Van Zanten SJ; Lind T; Mégraud F; Delchier JC; Hellblom M; Stubberöd A; Burman CF; Gromark P; Zeijlon L
    Helicobacter; 2000 Dec; 5(4):196-201. PubMed ID: 11179983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy.
    Zanten SJ; Bradette M; Farley A; Leddin D; Lind T; Unge P; Bayerdörffer E; Spiller RC; O'Morain C; Sipponen P; Wrangstadh M; Zeijlon L; Sinclair P
    Aliment Pharmacol Ther; 1999 Mar; 13(3):289-95. PubMed ID: 10102960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two 1-week low-dose omeprazole triple therapies--optimal treatment for Helicobacter pylori infection?
    Goh KL; Parasakthi N; Chuah SY; Cheah PL; Lo YL; Chin SC
    Aliment Pharmacol Ther; 1997 Dec; 11(6):1115-8. PubMed ID: 9663838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of omeprazole and metronidazole with amoxycillin or clarithromycin for Helicobacter pylori eradication, in a region of high primary metronidazole resistance: the HERO study.
    Katelaris PH; Adamthwaite D; Midolo P; Yeomans ND; Davidson G; Lambert J
    Aliment Pharmacol Ther; 2000 Jun; 14(6):751-8. PubMed ID: 10848659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equally high efficacy of 4, 7 and 10-day triple therapies to eradicate Helicobacter pylori infection in patients with ulcer disease.
    Hurenkamp GJ; Van Der Ende A; Grundmeijer HG; Tytgat GN; Van Der Hulst RW
    Aliment Pharmacol Ther; 2000 Aug; 14(8):1065-70. PubMed ID: 10930901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.
    Lee JM; Breslin NP; Hyde DK; Buckley MJ; O'Morain CA
    Aliment Pharmacol Ther; 1999 Apr; 13(4):489-96. PubMed ID: 10215733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment regimens for Helicobacter pylori infection in children: is in vitro susceptibility testing helpful?
    Faber J; Bar-Meir M; Rudensky B; Schlesinger Y; Rachman E; Benenson S; Sirota G; Stankiewic H; Halle D; Wilschanski M
    J Pediatr Gastroenterol Nutr; 2005 May; 40(5):571-4. PubMed ID: 15861018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer disease: results of a multicentre study in South-East Asia. South-East Asia Multicenter Study Group.
    Fock KM; Chelvam P; Lim SG
    Aliment Pharmacol Ther; 2000 Feb; 14(2):225-31. PubMed ID: 10651664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Famotidine versus omeprazole in combination with clarithromycin and metronidazole for eradication of Helicobacter pylori--a randomized, controlled trial.
    Gschwantler M; Dragosics B; Schütze K; Wurzer H; Hirschl AM; Pasching E; Wimmer M; Klimpfinger M; Oberhuber G; Brandstätter G; Hentschel E; Weiss W
    Aliment Pharmacol Ther; 1999 Aug; 13(8):1063-9. PubMed ID: 10468682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.
    Pilotto A; Franceschi M; Rassu M; Leandro G; Bozzola L; Furlan F; Di Mario F
    Dig Liver Dis; 2000 Nov; 32(8):667-72. PubMed ID: 11142574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study.
    Peitz U; Sulliga M; Wolle K; Leodolter A; Von Arnim U; Kahl S; Stolte M; Börsch G; Labenz J; Malfertheiner P
    Aliment Pharmacol Ther; 2002 Feb; 16(2):315-24. PubMed ID: 11860415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication.
    Ellenrieder V; Boeck W; Richter C; Marre R; Adler G; Glasbrenner B
    Scand J Gastroenterol; 1999 Aug; 34(8):750-6. PubMed ID: 10499474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of omeprazole, metronidazole and clarithromycin with omeprazole/amoxicillin dual-therapy for the cure of Helicobacter pylori infection.
    Miehlke S; Meining A; Lehn N; Höchter W; Weingart J; Simon T; Krämer W; Klann H; Bolle K; Sommer A; Stolte M; Bayerdörffer E
    Digestion; 1998; 59(6):646-50. PubMed ID: 9813387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary resistance to antibiotics and its clinical impact on the efficacy of Helicobacter pylori lansoprazole-based triple therapies.
    Poon SK; Chang CS; Su J; Lai CH; Yang CC; Chen GH; Wang WC
    Aliment Pharmacol Ther; 2002 Feb; 16(2):291-6. PubMed ID: 11860412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of omeprazole and clarithromycin combined with either metronidazole or amoxycillin in patients with metronidazole-resistant or -susceptible Helicobacter pylori strains.
    Houben MH; Hensen EF; Rauws EA; Hulst RW; Hoff BW; Ende AV; Kate FJ; Tytgat GN
    Aliment Pharmacol Ther; 1999 Jul; 13(7):883-9. PubMed ID: 10383522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acquisition of secondary resistance after failure of a first treatment of Helicobacter pylori infection in children].
    Kalach N; Benhamou PH; Bergeret M; Gottrand F; Husson MO; Barbier C; Dupont C; Raymond J
    Arch Pediatr; 2002 Feb; 9(2):130-5. PubMed ID: 11915493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study.
    Lind T; Veldhuyzen van Zanten S; Unge P; Spiller R; Bayerdörffer E; O'Morain C; Bardhan KD; Bradette M; Chiba N; Wrangstadh M; Cederberg C; Idström JP
    Helicobacter; 1996 Sep; 1(3):138-44. PubMed ID: 9398894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.